Brind.

AngioDynamics' Auryon Atherectomy System is currently being tested in clinical trials.

2 reports, 2 independent Updated Jul 28
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

AngioDynamics' Auryon Atherectomy System is currently being tested in clinical trials.

Who's involved

What this event is mainly about
AngioDynamics (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. Auryon Atherectomy System is undergoing clinical trials.1 source
  2. CE mark approval achieved for Auryon Atherectomy System.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireAngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee B
  • GuruFocus.comAngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... Total Revenue: $80.2 million, representing growth of over 12% year-over-year. Med Tech Revenue: $35.8